Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.74% | 178.19 | 0.7% | $1350.94m | |
| MRK | Merck & Co., Inc. | 0.21% | 92.61 | 0.7% | $1211.55m | |
| PFE | Pfizer Inc. | -1.20% | 51.68 | 0.9% | $1096.02m | |
| LLY | Eli Lilly & Co. | 0.74% | 327.13 | 1.1% | $1026.00m | |
| BMY | Bristol-Myers Squibb Co. | -1.13% | 75.97 | 1.0% | $991.64m | |
| ABBV | AbbVie, Inc. | 0.03% | 153.85 | 1.9% | $959.73m | |
| AZN | AstraZeneca Plc | -0.67% | 65.51 | 1.0% | $470.96m | |
| SGEN | Seagen Inc. | -1.85% | 176.77 | 5.7% | $326.06m | |
| GSK | GSK Plc | -1.01% | 43.31 | 0.2% | $272.45m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.05% | 75.15 | 0.0% | $199.28m | |
| HZNP | Horizon Therapeutics Plc | 2.38% | 82.76 | 5.4% | $174.09m | |
| NVS | Novartis AG | -0.11% | 84.27 | 0.2% | $172.25m | |
| MRTX | Mirati Therapeutics, Inc. | 1.10% | 71.96 | 1.6% | $150.81m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 1.67% | 150.73 | 8.1% | $150.31m | |
| NVO | Novo Nordisk A/S | -0.40% | 111.19 | 0.1% | $148.30m |
Company Profile
Amryt Pharma Plc is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded by Joseph Amrit Wiley and Rory Peter Nealon on August 28, 2015 and is headquartered in Dublin, Ireland.